Skip to main content

Table 2 Molecular characteristics of colon adenocarcinoma patients

From: Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma

Feature

Classification

n (%)

MGMT methylation status

Unmethylated

24 (21.8)

 

Methylated

86 (78.2)

Percentage MGMT expression

Low

55 (48.2)

 

High

59 (51.8)

MGMT expression intensity

Low

30 (26.3)

 

High

84 (73.7)

Percentage CD133 expression

Low

52 (47.3)

 

High

58 (52.7)

CD133 expression intensity

Low

70 (63.6)

 

High

40 (36.4)

  1. Sample size for MGMT methylation status (n = 110), for percentage MGMT expression (n = 114), MGMT expression intensity (n = 114), percentage CD133 expression (n = 110), and CD133 expression intensity (n = 110).
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us